SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients
This cohort study assesses the risk of development of type 2 diabetes in pediatric patients aged 10 to 19 years after receiving a COVID-19 diagnosis compared with the risk after other non–COVID-19 respiratory infections during the first 2 years of the pandemic.